Literature DB >> 15799792

Surgical technique of lumbar artificial disc replacement with the Charité artificial disc.

Fred H Geisler1.   

Abstract

Lumbar artificial disc technology has been commercially available outside the United States for nearly 2 decades. With the Food and Drug Administration approval of the Charité Artificial Disc in October 2004, an entirely new spinal surgeon population will be able to offer this technology to their patients as a treatment option. As with other techniques in spinal surgery, indications for lumbar total disc replacement are paramount to the success of the procedure. The correct surgical technique is also important to a successful outcome. This article describes the technique for placement of the Charité Artificial Disc in indicated patients. The technique is similar to that of an anterior lumbar interbody fusion procedure, but many differences between the techniques make lumbar total disc replacement a unique procedure in the spinal surgeon's armamentarium. Although this article is thorough in its description of the surgical technique for total disc replacement with the Charité Artificial Disc, it should not be used as a substitute for company-sponsored training.

Entities:  

Mesh:

Year:  2005        PMID: 15799792     DOI: 10.1227/01.neu.0000153215.60994.d3

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

1.  Prospective clinical and radiographic results of CHARITÉ III artificial total disc arthroplasty at 2- to 7-year follow-up: a Canadian experience.

Authors:  Michael Katsimihas; Christopher S Bailey; Khalil Issa; Jennifer Fleming; Patricia Rosas-Arellano; Stewart I Bailey; Kevin R Gurr
Journal:  Can J Surg       Date:  2010-12       Impact factor: 2.089

2.  Solid fusion after lumbosacral arthroplasty.

Authors:  Sang-Hoon Jang; Ho-Yeon Lee; Ji-Young Cho; Sang-Ho Lee
Journal:  World J Orthop       Date:  2013-07-18

3.  An 11-year minimum follow-up of the Charite III lumbar disc replacement for the treatment of symptomatic degenerative disc disease.

Authors:  Shi-bao Lu; Yong Hai; Chao Kong; Qing-yi Wang; Qingjun Su; Lei Zang; Nan Kang; Xiang-long Meng; Yu Wang
Journal:  Eur Spine J       Date:  2015-04-21       Impact factor: 3.134

4.  Long-term outcome after implantation of prosthetic disc nucleus device (PDN) in lumbar disc disease.

Authors:  P Selviaridis; N Foroglou; A Tsitlakidis; A Hatzisotiriou; I Magras; I Patsalas
Journal:  Hippokratia       Date:  2010-07       Impact factor: 0.471

5.  Heterotopic ossification following lumbar total disc replacement.

Authors:  Se-Jun Park; Kyung-Jung Kang; Seong-Kee Shin; Sung-Soo Chung; Chong-Suh Lee
Journal:  Int Orthop       Date:  2010-07-21       Impact factor: 3.075

6.  Complications of Lumbar Artificial Disc Replacement Compared to Fusion: Results From the Prospective, Randomized, Multicenter US Food and Drug Administration Investigational Device Exemption Study of the Charité Artificial Disc.

Authors:  Richard T Holt; Mohammed E Majd; Jorge E Isaza; Scott L Blumenthal; Paul C McAfee; Richard D Guyer; Stephen H Hochschuler; Fred H Geisler; Rolando Garcia; John J Regan
Journal:  SAS J       Date:  2007-02-01

7.  Load-transfer in the human vertebral body following lumbar total disc arthroplasty: Effects of implant size and stiffness in axial compression and forward flexion.

Authors:  Noah B Bonnheim; Tony M Keaveny
Journal:  JOR Spine       Date:  2020-01-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.